4.6 Article

Prevalence of Licit and Illicit Drugs Use during Pregnancy in Mexican Women

Related references

Note: Only part of the references are listed.
Review Substance Abuse

Prenatal methamphetamine-impact on the mother and child-a review

Fatima Anne Perez et al.

Summary: Pregnant women who use methamphetamine are at higher risk for worse pregnancy outcomes and co-existing health problems. Babies exposed to methamphetamine are more likely to experience difficulties in neonatal adaptation and feeding compared to babies exposed to other drugs. Studies suggest that neurocognitive deficits in children exposed to methamphetamine may persist into adulthood.

ADDICTION (2022)

Article Chemistry, Analytical

Assessment of licit and illicit drugs consumption during pregnancy by Ultra-High Performance Liquid Chromatography-High Resolution Mass Spectrometry (UHPLC-HRMS) target screening in Mexican women hair

Emilia Marchei et al.

Summary: Substance use in pregnancy is a global public health problem, and hair analysis can objectively assess maternal consumption of substances, which is important for assessing the risk of fetal exposure to toxic substances.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2022)

Review Environmental Sciences

Neonatal Outcomes after Combined Opioid and Nicotine Exposure in Utero: A Scoping Review

Krystyna R. Isaacs et al.

Summary: The majority of pregnant women with opioid use disorder also smoke tobacco but often lack tobacco cessation counseling. The impact of combined exposure to opioids and nicotine in utero on neonatal outcomes is not well-understood. Studies have shown a reduction in birth weight and length for infants with combined exposure to opioids and nicotine, with mixed findings on other neonatal outcomes such as NAS duration and severity. Additional research is needed to accurately predict these outcomes based on dosage and length of nicotine exposure during pregnancy.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Biology

Role of Neonatal Biomarkers of Exposure to Psychoactive Substances to Identify Maternal Socio-Demographic Determinants

Pilar Jarque et al.

Summary: Through studying 372 mothers, it was found that maternal characteristics such as age < 24 years, lack of pregnancy care, single-mother families, and active tobacco smoking were major indicators of maternal substance use during pregnancy. These profiles can help in identifying newborns exposed to psychoactive drugs.

BIOLOGY-BASEL (2021)

Article Chemistry, Analytical

Optimization of a rapid sample pretreatment for the quantification of COCAINE and its main metabolites in hair through a new and validated GC-MS/MS method

Nunzia La Maida et al.

Summary: The developed method is a rapid and sensitive gas chromatography-tandem mass spectrometry approach for determining cocaine and its metabolites in hair, achieving a high sensitivity of 0.01 ng/mg. The method's main advantages include its fast, simple, and innovative pretreatment procedure, as well as the ability to measure less concentrated metabolites.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2021)

Article Medicine, General & Internal

Association of Prenatal Exposure to Maternal Drinking and Smoking With the Risk of Stillbirth

Hein Odendaal et al.

Summary: This cohort study found that dual exposure to drinking and smoking after the first trimester of pregnancy was associated with nearly 3 times the risk of late stillbirth compared with no exposure or quitting before the end of the first trimester, suggesting a significantly increased risk.

JAMA NETWORK OPEN (2021)

Review Obstetrics & Gynecology

Prevalence and outcomes of prenatal recreational cannabis use in high-income countries: a scoping review

S. Singh et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)

Article Medical Laboratory Technology

Monitoring Prenatal Exposure to Buprenorphine and Methadone

Annagiulia Di Trana et al.

THERAPEUTIC DRUG MONITORING (2020)

Article Psychology, Clinical

A Qualitative Analysis of the Perceived Advantages and Disadvantages of Continuing or Discontinuing Substance Use Among Mexicans Seeking Treatment

Nestor Noyola et al.

INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION (2020)

Article Public, Environmental & Occupational Health

Determinants of Women's Drug Use During Pregnancy: Perspectives from a Qualitative Study

Gitau Mburu et al.

MATERNAL AND CHILD HEALTH JOURNAL (2020)

Article Multidisciplinary Sciences

Prevalence of Illicit Drug Use During Pregnancy: A Global Perspective

Ronan A. Tavella et al.

ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2020)

Article Substance Abuse

Treatment for substance use disorders in pregnant women: Motivators and barriers

Zane Frazer et al.

DRUG AND ALCOHOL DEPENDENCE (2019)

Article Pharmacology & Pharmacy

Self-medication practice in pregnant women from central Mexico

Angel Josabad Alonso-Castro et al.

SAUDI PHARMACEUTICAL JOURNAL (2018)

Review Public, Environmental & Occupational Health

Prevalence of prenatal exposure to substances of abuse: questionnaire versus biomarkers

Antonella Chiandetti et al.

REPRODUCTIVE HEALTH (2017)

Article Obstetrics & Gynecology

Self-reported and laboratory evaluation of late pregnancy nicotine exposure and drugs of abuse

E. S. Hall et al.

JOURNAL OF PERINATOLOGY (2016)

Review Obstetrics & Gynecology

Epidemiology of medications use in pregnancy

Martina Ayad et al.

SEMINARS IN PERINATOLOGY (2015)

Article Medical Laboratory Technology

Maternal Hair Analysis for the Detection of Illicit Drugs, Medicines, and Alcohol Exposure During Pregnancy

Elena Lendoiro et al.

THERAPEUTIC DRUG MONITORING (2013)

Review Public, Environmental & Occupational Health

Prescription drug use during pregnancy in developed countries: a systematic review

Jamie R. Daw et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)

Article Neurosciences

Psychoactive substance use during pregnancy: A review

S. Lamy et al.

ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2010)

Article Pharmacology & Pharmacy

Perception of risk regarding the use of medications and other exposures during pregnancy

Hedvig Nordeng et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)